Please speak with us about what products are backed by reputable studies before you buy
Kerr JB, Myers M, Anderson RA
When GLP-1 medications started reshaping the weight loss industry, Optavia pivoted
10.1002/path.4096 26 DorskyR
As reported on MedicalXpress, the European Medicines Agencys Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for several therapies this cycle, including a conditional endorsement that could bring Novo Nordisks semaglutide to European patients with metabolic dysfunctionassociated steatohepatitis (MASH)
PlexusDx offers Compounded Tirzepatide Injection ($289/mo) or GLP-Squared Injection (dual compound, $289/mo) as next steps, allowing your provider to engage multiple appetite-control pathways simultaneously